Shareholding disclosure

Lagoda Investment Management, L.L.C

Declared position

Threshold

Fell below threshold

Timeline

Published

10.11.2017

Transaction

02.11.2017

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAHB900012

Beneficial owner

Lagoda Investment Management, L.L.C

Declared address

Lagoda Investment Management, L.L.C., New York, NY

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Lagoda Investment Management, L.L.C

Santhera Pharmaceuticals Holding AG10.11.2017TAHB900012

Disclosure summary

Lagoda Investment Management, L.L.C disclosed a holding in Santhera Pharmaceuticals Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 10.11.2017, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Lagoda Investment Management, L.L.C disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 10.11.2017.

Publication date10.11.2017

Transaction date02.11.2017

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerLagoda Investment Management, L.L.C

Declared addressLagoda Investment Management, L.L.C., New York, NY

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAHB900012

Source: SIX Exchange Regulation · Publication date: 10.11.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open